Inferior Vena Cava Filters

Marron, R.; Rali, Parth; Hountras, Peter; Bull, Todd

doi:10.1016/j.chest.2020.08.002

Cited by 38 publications

(32 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…IVCFs are usually indicated for patients at high risk of venous thromboembolism who have absolute contraindications to anticoagulation or exhibit recurrent thromboembolic events despite adequate anticoagulation therapy. 5 , 6 , 8–10 Albeit an IVCF provides benefit in these scenarios, its presence may hinder interventional procedures necessitating delivery systems to advance through the inferior vena cava.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Patent foramen ovale closure in a patient with vena cava filter: a case report

Omedè

Bocchino

Filippo

et al. 2021

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Background The presence of a patent foramen ovale (PFO) is associated with several medical conditions, including cryptogenic left circulation thromboembolism. PFO closure was demonstrated to reduce recurrent ischaemic stroke in patients with prior cryptogenic stroke. The presence of an inferior vena cava filter (IVCF), however, may impede a transfemoral PFO closure procedure. Case summary We describe the case of a 50-year-old man with a PFO suffering from ischaemic stroke from paradoxical thromboembolism originating from deep vein thrombosis and requiring an IVCF. After deep vein thrombosis resolution, due to the high risk of stroke recurrences, the patient was recommended PFO closure. IVCF retrieval by the interventional radiologist was first attempted but failed. A transfemoral PFO closure procedure was thus endeavoured with the IVCF in place and was successful. The patient was then discharged in good clinical status and no stroke recurrences were reported at 5 months follow-up. Discussion Albeit an IVCF provides benefit in patients with recurrent thromboembolic events despite adequate anticoagulation therapy, its presence may hinder interventional procedures necessitating delivery systems to advance through the inferior vena cava. We reported on a successful PFO closure procedure via a femoral venous access in a patient with an IVCF in place, thus demonstrating the feasibility of advancing delivery systems through an IVCF. As interventional procedures requiring the advancement of delivery systems through the inferior vena cava are becoming increasingly common, the feasibility of IVCF crossing with catheters and delivery systems alike paves the way for novel interventional possibilities.

show abstract

Section: Discussionmentioning

confidence: 99%

“… 1 Notwithstanding, patients with contraindications for oral anticoagulation or recurrent venous thromboembolism despite adequate anticoagulation therapy may have been implanted an inferior vena cava filter (IVCF), which proves a challenge for interventional procedures going through the inferior vena cava. 5 , 6 …”

Section: Introductionmentioning

confidence: 99%

Patent foramen ovale closure in a patient with vena cava filter: a case report

Omedè

Bocchino

Filippo

et al. 2021

European Heart Journal - Case Reports

View full text Add to dashboard Cite

show abstract

“…IVC plication or ligation was utilized in the 1930s to prevent DVT embolization to the pulmonary arteries before anticoagulation became the treatment of choice. 2 3 Anticoagulation has been the preferred treatment for VTE since the 1940s. 3 In 1967, Dr. Kazi Mobin-Uddin developed the first endovascular IVCF at the University of Miami.…”

Section: Historymentioning

confidence: 99%

“…17 In response, recommendations for filter use by societal guidelines were narrowed. 2 During the following years, retrieval rates for IVCF increased and IVCF placement decreased, with recent reports estimating that approximately 25% of filters are now placed for prophylaxis. 18 To date, there remains a scarcity of large randomized clinical trials to support IVCF use, with most studies limited to observational or retrospective analyses.…”

Section: Patient Populationmentioning

confidence: 99%

Back to the Basics: Inferior Vena Cava Filters

Covello

Radvany

2022

Semin intervent Radiol

View full text Add to dashboard Cite

Inferior vena cava filters are an important therapeutic option for patients with venous thromboembolism and contraindication to anticoagulation. Indications for filter placement have varied over the previous decades. This article discusses the history of inferior vena cava filter use, with a basic overview of technology and specific devices. Finally, this article reviews emerging filter design and technology. Understanding the basics of inferior vena cava filters is critical to building more robust clinical data for the purpose of improving patient outcomes.

show abstract

“…1 The use of IVCFs has expanded, such as for venous thromboembolism prophylaxis in bariatric surgery. 1,2 In 2010, a study identified IVCF-associated harms, including filter fractures, embolization, and deaths. 3 Publication prompted an immediate US Food and Drug Administration (FDA) safety advisory noting there had been nearly 1000 IVCF adverse event (AE) reports and reminded physicians to remove devices that could be retrieved.…”

mentioning

confidence: 99%